Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)
China
· Delayed Price · Currency is CNY 6.58
+0.03 (0.46%)
Apr 29, 2026, 3:00 PM CST
SHA:600223 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 6,689 | 7,482 | 7,685 | 9,790 | 10,765 | 13,371 | Upgrade
|
| Market Cap Growth | -12.62% | -2.65% | -21.50% | -9.06% | -19.49% | 55.57% | Upgrade
|
| Enterprise Value | 4,712 | 5,633 | 5,881 | 12,411 | 15,213 | 21,219 | Upgrade
|
| Last Close Price | 6.58 | 7.36 | 7.51 | 9.34 | 10.27 | 12.69 | Upgrade
|
| PE Ratio | 41.10 | 39.85 | 31.56 | 32.27 | 236.84 | 36.95 | Upgrade
|
| Forward PE | 27.80 | 33.64 | 33.64 | 33.64 | 33.64 | 33.64 | Upgrade
|
| PS Ratio | 1.82 | 2.05 | 1.93 | 2.14 | 0.83 | 1.08 | Upgrade
|
| PB Ratio | 1.34 | 1.51 | 1.61 | 2.09 | 1.93 | 2.06 | Upgrade
|
| P/TBV Ratio | 1.70 | 1.91 | 2.03 | 2.64 | 3.20 | 3.07 | Upgrade
|
| P/FCF Ratio | 24.92 | 45.13 | 107.58 | 37.25 | 12.94 | 2.04 | Upgrade
|
| P/OCF Ratio | 18.38 | 27.09 | 33.61 | 20.65 | 10.79 | 1.95 | Upgrade
|
| EV/Sales Ratio | 1.28 | 1.54 | 1.48 | 2.71 | 1.18 | 1.72 | Upgrade
|
| EV/EBITDA Ratio | 18.99 | 20.34 | 18.91 | 34.14 | 21.98 | 29.09 | Upgrade
|
| EV/EBIT Ratio | 34.22 | 32.51 | 27.39 | 54.51 | 26.43 | 33.32 | Upgrade
|
| EV/FCF Ratio | 17.56 | 33.98 | 82.33 | 47.23 | 18.29 | 3.23 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.03 | 0.06 | 0.47 | 1.39 | 1.43 | Upgrade
|
| Debt / EBITDA Ratio | 0.49 | 0.49 | 0.90 | 5.81 | 11.09 | 12.71 | Upgrade
|
| Debt / FCF Ratio | 0.83 | 0.83 | 4.00 | 8.30 | 9.30 | 1.41 | Upgrade
|
| Net Debt / Equity Ratio | -0.56 | -0.56 | -0.56 | 0.10 | 0.61 | 0.64 | Upgrade
|
| Net Debt / EBITDA Ratio | -9.96 | -9.96 | -8.56 | 1.23 | 4.94 | 5.69 | Upgrade
|
| Net Debt / FCF Ratio | -16.64 | -16.64 | -37.26 | 1.71 | 4.11 | 0.63 | Upgrade
|
| Asset Turnover | 0.62 | 0.62 | 0.58 | 0.14 | 0.22 | 0.20 | Upgrade
|
| Inventory Turnover | 3.48 | 3.48 | 3.49 | 0.11 | 0.21 | 0.20 | Upgrade
|
| Quick Ratio | 4.08 | 4.08 | 3.16 | 2.25 | 0.12 | 0.13 | Upgrade
|
| Current Ratio | 4.71 | 4.71 | 3.75 | 2.49 | 1.10 | 1.15 | Upgrade
|
| Return on Equity (ROE) | 4.88% | 4.88% | 6.26% | 7.15% | 1.08% | 6.05% | Upgrade
|
| Return on Assets (ROA) | 1.83% | 1.83% | 1.94% | 0.43% | 0.60% | 0.65% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.38% | 6.69% | 5.07% | 2.86% | 1.46% | 3.31% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.50% | 3.50% | 4.40% | 4.20% | 7.30% | 6.20% | Upgrade
|
| Earnings Yield | 2.53% | 2.51% | 3.17% | 3.10% | 0.42% | 2.71% | Upgrade
|
| FCF Yield | 4.01% | 2.22% | 0.93% | 2.68% | 7.73% | 49.11% | Upgrade
|
| Dividend Yield | 0.87% | 0.77% | 1.47% | 1.07% | 1.07% | 0.87% | Upgrade
|
| Payout Ratio | 37.79% | 34.72% | 75.38% | 160.84% | 2585.08% | 556.88% | Upgrade
|
| Buyback Yield / Dilution | -2.80% | -2.80% | -0.34% | 11.01% | -9.90% | -2.00% | Upgrade
|
| Total Shareholder Return | -1.96% | -2.02% | 1.13% | 12.08% | -8.83% | -1.13% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.